جستجوی استاد راهنمای دانشگاهی

Brian D. Gulbransenمشاهده پروفایل

استاد

• Neuroinflammation
• Neuroglia
• Enteric Nervous System
• +۵ مورد دیگر

Brian D. Gulbransen is a Professor in the Department of Physiology at Michigan State University, holding the MSU Research Foundation Professorship. His work focuses on neuroinflammation and enteric nervous system (ENS) biology, particularly neuron-glia interactions in gut physiology and disease. Department of Physiology, Michigan State University MSU Research Foundation Professor Research Interests : Understanding how neuroinflammation alters neural circuitry through glial cell mechanisms, with applications to functional bowel disorders like IBS and IBD. Key techniques include fluorescence microscopy, genetic models (DREADDs, cell-specific knockouts), electrophysiology, organ physiology, and transcriptomics. Scientific Trends : Analysis of his 15 most recent publications reveals: Purinergic signaling (P2X7, P2Y receptors) Enteric glia-neuron-macrophage crosstalk Role of connexin-43 hemichannels Microbiota-glia interactions Stress-induced gut dysfunction Neuroimmune regulation of motility Education : University of Wyoming (B.S. Zoology & Physiology, 2003) University of Colorado Anschutz (Ph.D. Neuroscience, 2007) University of Calgary (Postdoctoral Fellow, 2014) Collaborations span neurogastroenterology, immunology, and metabolic disease research, with grants supporting studies on neuroinflammation, microbiome interactions, and gut motility disorders.

• Dendrimers
• Drug Delivery
• Antimicrobial Agents
• +۵ مورد دیگر

Jørn Bolstad Christensen serves as an Associate Professor in the Department of Chemistry at the University of Copenhagen, Denmark, with research spanning dendrimer chemistry, nanomedicine, and pharmaceutical applications. His work addresses critical drug delivery challenges including mucosal barriers, antimicrobial resistance, and targeted release systems, supported by over 180 research outputs across journals, books, and patents. Christensen's research centers on dendrimers and nanocarriers for biomedical applications, with emphasis on antimicrobial agents (e.g., phenothiazine derivatives), photodynamic therapy (e.g., phthalocyanine-cored dendrimers), and oral drug delivery systems. Recent projects investigate polymeric micelle-mucin interactions, pH-sensitive polymersomes for immunosuppressant delivery, and structure-toxicity relationships in PAMAM dendrimers, highlighting interdisciplinary approaches combining synthetic chemistry and biological evaluation. His publication trends (2023-2025) reveal strong focus on overcoming biological barriers through nanotechnology, particularly for antimicrobial and neurological applications. Work frequently involves computational modeling alongside experimental validation, with emphasis on stereochemistry, carrier geometry, and surface functionalization to optimize efficacy and reduce toxicity. Christensen actively contributes to academic discourse through lectures on dendrimer applications and antimicrobial research, including presentations at international conferences. He serves on review committees and performs peer review, demonstrating commitment to scholarly service and student supervision as evidenced by co-examiner roles. Media recognition includes coverage of patented resistance solutions (2016) and dendrimer applications in biotechnology (2008), reflecting translational impact of his research in pharmaceutical sciences.

• Morphogenesis and differentiation of the gastrointestinal mucosa
• Bioinformatics interpretation of molecular profiles
• Transcriptome analysis
• +۷ مورد دیگر

Jørgen Olsen is a Professor at the Department of Cellular and Molecular Medicine, University of Copenhagen, specializing in the Morphogenesis and Differentiation Program within the Faculty of Health and Medical Sciences. His research focuses on gastrointestinal mucosa development and inflammatory bowel diseases, with significant contributions to translational medicine including the discovery of rectal insulin as a potential treatment for colitis. Dr. Olsen received his Medical Doctor degree from the University of Copenhagen in 1992 and his Doctor Medicinae (DMSc) from the Faculty of Health Sciences at the same institution in 1998. His academic journey progressed from research assistant to professor, with appointments at the Department of Medical Biochemistry & Genetics and later the Department of Cellular & Molecular Medicine. His primary research interests center on morphogenesis and differentiation of the gastrointestinal mucosa, with special focus on bioinformatics interpretation of alterations in molecular profiles (transcriptome, metabolome) during mucosal inflammation. His laboratory uses mouse models for intestinal inflammation which are translated into applied research for inflammatory bowel diseases. A significant recent discovery involves the use of rectal insulin as treatment for inflammatory bowel disease, where his team demonstrated that colitis in mice can be treated using rectal instillation of insulin. Analysis of his recent publications reveals a strong focus on medical education during the pandemic era, particularly regarding student perspectives on death, body donation, and professional identity formation. His earlier work shows consistent expertise in gastrointestinal biology, molecular mechanisms of inflammation, and bioinformatics approaches to understanding mucosal disorders. The research spans basic science through clinical translation, with increasing international collaboration in recent years. Dr. Olsen has served as supervisor for 7 PhD students, 12 masters students, and 2 scholar stipend students, and has participated in evaluation committees for numerous academic positions and theses. His teaching innovations include "The Modern Anatomical Theater," "Q+A livestreamed sessions," and digital learning resources. His research has been supported by multiple grants from the Novo Nordisk Foundation, Danish Medical Research Council, and other organizations, totaling over 4 million DKK in awarded funding. He is also CEO and co-founder of Enterotarget ApS, which holds a license agreement with the University of Copenhagen for the patent "Rectal insulin for treatment of inflammatory bowel disease" (EP3538132A1).

David C. Niemanمشاهده پروفایل

استاد

• Exercise Immunology
• Nutrition Immunology
• Exercise-Induced Inflammation
• +۵ مورد دیگر

David C. Nieman, DrPH, FACSM is a Professor in the Department of Biology within the College of Arts and Sciences at Appalachian State University and serves as Director of the Human Performance Laboratory at the North Carolina Research Campus (NCRC) in Kannapolis, NC. With over three decades of pioneering research in exercise immunology, Dr. Nieman has established himself as a leader in understanding the relationship between physical activity, nutrition, and immune function. Dr. Nieman's research interests focus on exercise and nutrition immunology, with particular emphasis on how regular moderate exercise lowers upper respiratory tract infection rates while improving immunosurveillance, how heavy exertion increases infection rates through transient immune changes, and how nutritional interventions like carbohydrate and flavonoid ingestion can mitigate exercise-induced inflammation. His current work employs multi-omics approaches to investigate nutritional products as countermeasures for exercise- and obesity-induced immune dysfunction, inflammation, and oxidative stress. Dr. Nieman has received more than $10.9 million in research grants and published over 370 peer-reviewed publications, earning a Google Scholar h-index of 101 with over 41,000 citations. His recent work shows increasing focus on metabolomics, proteomics, and microbiome research to understand exercise-induced immune changes at a molecular level, with particular attention to nutritional interventions involving flavonoids, cranberry, beetroot, and other plant compounds. His scientific recognition includes: 100 Scholars Faculty Research Award from ASU (1997) Montoye Scholar Award from Southeastern American College of Sports Medicine (2006) ASU College of Fine and Applied Arts Researcher of the Year Award (2006) ACSM's Citation Award (2013) Multiple nominations for ASU's highest honor, the Oliver Max Gardner Award Dr. Nieman serves as Editor-in-Chief for the sports nutrition sections of Nutrients and Frontiers in Nutrition journals and sits on 10 editorial boards including Medicine and Science in Sports and Exercise. He has served in leadership roles as vice-president of the American College of Sports Medicine, president of SEACSM, and two-term president of the International Society of Exercise and Immunology. His work extends beyond academia as he has completed 58 marathons, demonstrating his personal commitment to the principles he researches.

• Endocrinology
• Metabolism
• Gastrointestinal Physiology
• +۴ مورد دیگر

Kaare Villum Grunddal is an Assistant Professor in the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research primarily focuses on endocrinology and metabolism, with particular expertise in gastrointestinal physiology, GLP-1 receptor studies, and diabetes research. Dr. Grunddal's research interests span multiple interconnected fields including endocrinology, metabolism, gastrointestinal physiology, and diabetes research. His work centers on understanding hormone signaling pathways, particularly those involving GLP-1 receptors, and their roles in metabolic regulation. He investigates how gastrointestinal hormones influence pancreatic function and glucose metabolism, with implications for diabetes treatment. His research also extends to cardiac repair mechanisms and intestinal tuft cell biology, exploring connections between the immune system, gut physiology, and metabolic disorders. Dr. Grunddal's publication record demonstrates significant contributions to cardiovascular research, molecular biology, and endocrinology. His most recent work published in Nature Cardiovascular Research (2024) explores novel mechanisms of cardiac repair involving macrophage-derived proteins and orphan receptors. Previous work has focused on GLP-1 receptor expression patterns, urocortin-3's role in glucose metabolism, and intestinal tuft cell biology in inflammatory conditions. His research has received notable attention in the scientific community, with several publications picked up by news outlets and blogged about. One paper was covered by 15 news outlets, and multiple publications have attracted significant readership on academic platforms like Mendeley, indicating their relevance and impact within the scientific community. Dr. Grunddal collaborates extensively with leading researchers in endocrinology and metabolism, including prominent figures such as Jens Juul Holst, with whom he has co-authored multiple publications. His work bridges basic science with potential clinical applications, particularly in the areas of diabetes treatment and cardiovascular repair mechanisms.

• Bacteriophage Therapy
• Food Safety
• Zoonotic Diseases
• +۵ مورد دیگر

Michela Gambino serves as an Assistant Professor in the Department of Veterinary and Animal Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on Food Safety and Zoonoses, with particular emphasis on bacteriophage applications for controlling bacterial pathogens in animal health and food production systems. Her research spans bacteriophage therapy against enteric pathogens, food safety interventions for meat processing, and veterinary microbiome dynamics . Key themes include developing phage-based alternatives to antibiotics in livestock, understanding host-pathogen interactions in porcine post-weaning diarrhea, and translating laboratory findings to industrial applications. Her work bridges veterinary science, microbiology, and food safety through interdisciplinary collaboration. Analysis of her recent publications reveals a strong trajectory in applied phage research , particularly targeting Enterobacteriaceae in animal models and food systems. Her studies integrate genetic susceptibility (e.g., CHCF1/SNP2 genotypes), microbiome analysis, and industrial-scale validation, demonstrating translational impact from bench to farm and food processing environments. No scientific awards were mentioned in the source material. Information regarding student advising and research grants was not explicitly provided in the available text. Dr. Gambino collaborates extensively within the Department of Veterinary and Animal Sciences (IVH), particularly with researchers specializing in gut microbiology, phage biology, and veterinary infectious diseases. Her work involves both controlled challenge trials and industrial-scale validations, indicating integration within applied research teams focused on sustainable solutions for animal health and food safety challenges.

• Skin Microbiome Research
• Host-Microbe Interactions
• Chronic Inflammatory Skin Diseases
• +۳ مورد دیگر

Lene Bay serves as Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen, with dual appointments in Bacteriology and the Skin Immunology Research Center. Her research focuses on the intricate relationships between skin microbiota and inflammatory diseases. Her educational background includes a PhD in The Human Skin Microbiota - distribution and composition, completed between January 2015 and February 2018, with the degree awarded on June 20, 2018. This foundational work established her expertise in cutaneous microbial ecosystems. Bay's research program investigates host-microbe interactions in chronic inflammatory skin conditions, particularly atopic dermatitis and hidradenitis suppurativa. Her work employs advanced metagenomic techniques to characterize bacterial communities within different skin microenvironments, revealing how microbial signatures correlate with disease states. Current projects examine intestinal-pulmonary inflammation connections, antimicrobial efficacy in medical devices, and preoperative skin preparation protocols. Analysis of her 33 research outputs shows consistent focus on skin microbiome dynamics, with significant contributions to understanding dermal bacterial signatures in inflammatory diseases. Her work bridges fundamental microbiology with clinical applications, particularly in diagnostic biomarker discovery and therapeutic intervention strategies. Bay maintains active research collaborations across multiple institutions, as evidenced by her international co-authorship network. Her work has generated substantial academic engagement with 15+ PlumX captures for recent publications and significant Mendeley readership. She is affiliated with the Skin Immunology Research Center and conducts research within the Department of Immunology and Microbiology's specialized laboratories. Her team utilizes both human clinical samples and porcine models to investigate skin barrier function and microbial colonization patterns.

Mark Smitsمشاهده پروفایل

پژوهشگر

• Endocrinology
• Metabolism
• Gut Hormone Physiology
• +۵ مورد دیگر

Mark Smits is a postdoctoral researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Biomedical Sciences, working within Professor Jens Juul Holst's research group focused on endocrinology and metabolism. His academic journey began with medical training in Amsterdam where he earned both Bachelor's and Master's degrees with honors from Vrije Universiteit Amsterdam. Medical Doctor (MD) qualification from Amsterdam PhD in gut-hormone based therapies from Vrije Universiteit Amsterdam (completed with honors) Current endocrinology specialist training Dr. Smits' research centers on gut hormone physiology, particularly mechanisms to enhance glucagon-like peptide-1 (GLP-1) secretion. His work spans molecular mechanisms of hormone secretion, dietary influences on metabolic pathways, and therapeutic applications for diabetes and metabolic disorders. Recent publications demonstrate expertise in incretin biology, gut-brain axis signaling, and translational approaches to metabolic disease. His collaborative research network spans multiple international institutions, with significant contributions to understanding GLP-1 secretion pathways, nutrient-hormone interactions, and metabolic adaptations in disease models. Dr. Smits has published over 65 peer-reviewed articles, with recent work appearing in high-impact journals including Diabetes , American Journal of Physiology , and Diabetes/Metabolism Research and Reviews . As part of Holst's renowned research group, he contributes to cutting-edge investigations into gut hormone-based therapies while advancing his clinical training in endocrinology. His dual expertise in clinical medicine and basic research positions him at the intersection of translational endocrinology and metabolic disease therapeutics.